Wegovy and Ozempic linked to reduced incidence and recurrence of alcohol abuse or dependence, study suggests

FHS
June 14, 2024
11:24 am

Researchers investigated the potential therapeutic benefits of semaglutide for alcohol use disorders.

Opinion | ‘It’s Total Charlatanism’: What We Heard This Week

“It’s total charlatanism.” — Thomas Albini, MD, of the University of Miami in Florida, discussing eye injuries from unproven stem cell treatments claiming to treat

July 3, 2023

Gene therapy shows promise for arrhythmogenic cardiomyopathy

Researchers evaluated the effectiveness of adeno-associated virus (AAV)-mediated Plakophilin 2 (PKP2) delivery in treating arrhythmogenic cardiomyopathy (ACM).

December 12, 2023

The effect of supplementation with cornelian cherry on different cardiometabolic outcomes

A recent meta-analysis in Nutrients examined recent studies on the cornelian cherry, Cornus mas L., for evidence of its cardiometabolic benefit.

July 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.